Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04433234
PHASE2
Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Sponsor: Daiichi Sankyo Co., Ltd.
View on ClinicalTrials.gov
Summary
This is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.
Official title: A Phase II, Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Key Details
Gender
MALE
Age Range
5 Years - Any
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2020-06-30
Completion Date
2027-01-31
Last Updated
2025-09-19
Healthy Volunteers
No
Conditions
Interventions
DRUG
DS-5141b
Administered via subcutaneous injection once weekly
Locations (2)
National Center of Neurology and Psychiatry
Tokyo, Kodaira-Shi, Japan
Kobe University Hospital
Hyōgo, Japan